Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen receptor function in chronic lymphocytic leukemia B cells

A C Lankester1, G M Schijndel, N G Pakker

  • 1Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, University of Amsterdam, The Netherlands.

Leukemia & Lymphoma
|December 1, 1996
PubMed
Summary

Two groups of B chronic lymphocytic leukemia (B-CLL) exhibit distinct responses to B-cell antigen receptor (BCR) cross-linking. Non-responsive B-CLL show lower levels of the protein tyrosine kinase syk, impacting BCR signaling and proliferation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITA.

The Journal of allergy and clinical immunology·2026
Same author

Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism.

Bone marrow transplantation·2026
Same author

Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT.

Blood·2022
Same author

Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases.

Bone marrow transplantation·2022
Same author

EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.

Bone marrow transplantation·2021
Same author

Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation.

British journal of clinical pharmacology·2019

Area of Science:

  • Immunology
  • Hematology
  • Molecular Biology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous malignancy.
  • The B-cell antigen receptor (BCR) plays a critical role in B-CLL cell survival and proliferation.
  • Functional differences in BCR signaling exist among B-CLL subtypes.

Purpose of the Study:

  • To investigate the molecular basis for differential proliferative responses in B-CLL.
  • To compare signaling pathways in responsive versus non-responsive B-CLL.
  • To explore the role of syk in B-CLL immunobiology and disease progression.

Main Methods:

  • Functional assays measuring proliferative response to BCR cross-linking.
  • Biochemical analysis of BCR complex components and associated signaling molecules.

Related Experiment Videos

  • Assessment of intracellular calcium ([Ca++]) flux and tyrosine phosphorylation.
  • Quantification of syk protein expression levels.

    • Main Results:

    • B-CLL cells were functionally divided into responsive and non-responsive groups based on BCR cross-linking.
    • Non-responsive B-CLL failed to exhibit tyrosine phosphorylation or increased intracellular calcium upon BCR ligation.
    • No significant structural differences were found in BCR complexes between the two groups.
    • Markedly lower expression of the protein tyrosine kinase syk was observed in non-responsive B-CLL.

    Conclusions:

    • The protein tyrosine kinase syk is a key determinant of B-CLL proliferative capacity.
    • Reduced syk expression impairs BCR signaling, leading to a non-proliferative phenotype in B-CLL.
    • These findings offer insights into B-CLL immunobiology and potential therapeutic targets for disease management.